The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Changes in nail colour, shape, or texture are not normal and can indicate underlying health issues, nutrient deficiencies, or ...

No matter what the season, I have a hand cream with (or near) me at all times to moisturize my dry skin and counteract any ...

Cleansing your face regularly is a healthy skincare practice. However, the way you do it matters, because if done carelessly, ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

UTC Just as drugstore shampoos are witnessing a resurgence — as shoppers realize that affordability does not always indicate ...

Topical Steroid Withdrawal Diagnostic Criteria Defined by NIH Researchers - Criteria May Help Guide Treatment of Dermatitis ...

Dermatologists wax poetic about changing your skin care routine with the seasons. As we head into the warmer spring months, ...